Schelleman H - Search Results

1

The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.

Schelleman H, Klungel OH, Witteman JC, Hofman A, van Duijn CM, de Boer A, Stricker BH. Schelleman H, et al. Eur J Hum Genet. 2006 Jul;14(7):860-6. doi: 10.1038/sj.ejhg.5201632. Epub 2006 May 17. Eur J Hum Genet. 2006. PMID: 16724011

2

Drug-gene interactions between genetic polymorphisms and antihypertensive therapy.

Schelleman H, Stricker BH, De Boer A, Kroon AA, Verschuren MW, Van Duijn CM, Psaty BM, Klungel OH. Schelleman H, et al. Drugs. 2004;64(16):1801-16. doi: 10.2165/00003495-200464160-00006. Drugs. 2004. PMID: 15301563 Review.

3

Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy.

Schelleman H, Klungel OH, van Duijn CM, Witteman JC, Hofman A, de Boer A, Stricker BH. Schelleman H, et al. Ann Pharmacother. 2006 Feb;40(2):212-8. doi: 10.1345/aph.1G316. Epub 2006 Jan 31. Ann Pharmacother. 2006. PMID: 16449550

4

Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.

Schelleman H, Klungel OH, Witteman JC, Breteler MM, Yazdanpanah M, Danser AH, Hofman A, van Duijn CM, de Boer A, Stricker BH. Schelleman H, et al. Eur J Hum Genet. 2007 Apr;15(4):478-84. doi: 10.1038/sj.ejhg.5201789. Epub 2007 Feb 14. Eur J Hum Genet. 2007. PMID: 17299437

5

Prevalence and determinants of undertreatment of hypertension in the Netherlands.

Schelleman H, Klungel OH, Kromhout D, de Boer A, Stricker BH, Verschuren WM. Schelleman H, et al. J Hum Hypertens. 2004 May;18(5):317-24. doi: 10.1038/sj.jhh.1001672. J Hum Hypertens. 2004. PMID: 15103311

6

Insertion/deletion polymorphism of the ACE gene and adherence to ACE inhibitors.

Schelleman H, Klungel OH, van Duijn CM, Witteman JC, Hofman A, de Boer A, Stricker BH. Schelleman H, et al. Br J Clin Pharmacol. 2005 Apr;59(4):483-5. doi: 10.1111/j.1365-2125.2004.02332.x. Br J Clin Pharmacol. 2005. PMID: 15801945 Free PMC article.

7

Interactions between five candidate genes and antihypertensive drug therapy on blood pressure.

Schelleman H, Stricker BH, Verschuren WM, de Boer A, Kroon AA, de Leeuw PW, Kromhout D, Klungel OH. Schelleman H, et al. Pharmacogenomics J. 2006 Jan-Feb;6(1):22-6. doi: 10.1038/sj.tpj.6500339. Pharmacogenomics J. 2006. PMID: 16314886

8

Diuretic-gene interaction and the risk of myocardial infarction and stroke.

Schelleman H, Klungel OH, Witteman JC, Breteler MM, Hofman A, van Duijn CM, de Boer A, Stricker BH. Schelleman H, et al. Pharmacogenomics J. 2007 Oct;7(5):346-52. doi: 10.1038/sj.tpj.6500428. Epub 2006 Dec 26. Pharmacogenomics J. 2007. PMID: 17189961

9

Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or beta-blocker use and the risk of myocardial infarction and stroke.

Schelleman H, Klungel OH, Witteman JC, Breteler MM, Hofman A, van Duijn CM, de Boer A, Stricker BH. Schelleman H, et al. Pharmacogenomics J. 2008 Dec;8(6):400-7. doi: 10.1038/sj.tpj.6500493. Epub 2008 Mar 18. Pharmacogenomics J. 2008. PMID: 18347611

10

Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or beta-blockers and the risk of atherosclerosis.

Schelleman H, Klungel OH, Witteman JC, Hofman A, van Duijn CM, de Boer A, Stricker BH. Schelleman H, et al. Br J Clin Pharmacol. 2007 Jul;64(1):57-66. doi: 10.1111/j.1365-2125.2007.02848.x. Epub 2007 Feb 12. Br J Clin Pharmacol. 2007. PMID: 17298481 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters